25 countries in queue for 'Made in India' Covid-19 vaccine: Jaishankar

India has so far supplied Covid-19 vaccine to 15 countries

S Jaishankar
S Jaishankar | File
Press Trust of India Amaravati
2 min read Last Updated : Feb 06 2021 | 3:22 PM IST

India has so far supplied COVID-19 vaccine to 15 countries and another 25 nations are in the queue at different levels for the jab, External Affairs Minister S Jaishankar said here on Saturday.

He said there are three categories of countries which are keen to get the vaccine from India- poor, price sensitive nations and other countries which directly deal with pharmaceutical companies that make the antidote.

"I think right now we have already supplied to about 15 countries (as per my recollection).

I would say there would be another about 25 countries which are at different stages in the pipeline. But what it has done is today it has put India on the map of the world," Jaishankar told reporters in a press conference.

The minister said some poor countries are being supplied the vaccine on a grant basis while some nations wanted it on par with the price that the Indian Government pays to the vaccine makers.

Some countries have directcontractswith the Indian vaccine producing companies and have negotiated commercially, he said.

The Centre has already given the nod for two COVID-19 vaccines-- Covaxin of city-based Bharat Biotech and Covishield of Oxford, being manufactured by Serum Institute of India in Pune, which are being administered to frontline workers from January 16, under Emergency Use Authorisation.

Drug maker Dr Reddys recently said it will approach the Drug Regulator for the EUA for Russian vaccine Sputnik V in March.

Jaishankar said Prime Minister Narendra Modis idea was to establish the country as the "Pharmacy of the World", taking advantage of the domestic capabilities and the way India emerged as IT leader during the Y2K issue.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusS JaishankarCoronavirus TestsCoronavirus Vaccine

First Published: Feb 06 2021 | 3:14 PM IST

Next Story